With 6,632 AD patients and 12,503 controls for IL-6-174 and -572 polymorphisms investigations included, the results from our studies consent to previous meta-analyses and may confirm that the IL-6 −174G/C polymorphism may be a protective factor for the development of AD. The gene discussed is IL6; the disease is Alzheimer disease.